Charles River Laboratories International Earnings

Charles River Laboratories International’s revenue fell -2.71% since last year same period to $984.17Mn in the Q1 2025. On a quarterly growth basis, Charles River Laboratories International has generated -1.83% fall in its revenue since last 3-months.

Charles River Laboratories International’s net profit fell -62.17% since last year same period to $25.47Mn in the Q1 2025. On a quarterly growth basis, Charles River Laboratories International has generated 111.81% jump in its net profits since last 3-months.

Charles River Laboratories International’s net profit margin fell -61.12% since last year same period to 2.59% in the Q1 2025. On a quarterly growth basis, Charles River Laboratories International has generated 112.03% jump in its net profit margins since last 3-months.

Charles River Laboratories International’s earning per share (EPS) estimates for the current quarter stand at 2.38 - a -4.8% fall from last quarter’s estimates.

Charles River Laboratories International’s earning per share (EPS) estimates for the current year stand at 2.38.

Charles River Laboratories International’s earning per share (EPS) fell -100% since last year same period to 0 in the Q3 2025. This indicates that the Charles River Laboratories International has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.